This inventor holds 5 USPTO granted patents and 3 published patent applications and 5 EPO patents. Top assignee: Merck Patent Gmbh. Active years: 2019-2026.
Company Filing History:
Years Active: 2019-2026
Title: Philippe Rivat: Innovator in Microbiological Testing
Introduction
Philippe Rivat is a notable inventor based in Dorlisheim, France. He has made significant contributions to the field of microbiological testing through his innovative inventions. With a total of 5 patents, Rivat continues to push the boundaries of technology in his area of expertise.
Latest Patents
One of Philippe Rivat's latest patents is a filtration assembly and method for microbiological testing. This invention involves a filtration assembly that comprises a ring-like membrane support holding a filtration membrane. The assembly includes a cylindrical reservoir with openings at both ends, where one end is designed to be fluid-tightly attached to the membrane support. This configuration defines a sample volume adjacent to the filtration membrane. Additionally, a lid device is included, which can be removably and fluid-tightly attached to the other end of the reservoir to close the opening. This innovative design allows for effective microbiological testing by sealing the sample from the environment.
Career Highlights
Philippe Rivat is currently associated with Merck Patent GmbH, where he applies his expertise in developing advanced filtration technologies. His work has been instrumental in enhancing the reliability and efficiency of microbiological testing methods.
Collaborations
Throughout his career, Rivat has collaborated with talented individuals such as Mathieu Arrault and Vincent Schaal. These collaborations have contributed to the successful development of his innovative technologies.
Conclusion
Philippe Rivat stands out as a key figure in the field of microbiological testing, with his inventive spirit leading to advancements that benefit the scientific community. His contributions continue to shape the future of testing methodologies.